Found: 29 articles

Article Edition
N.A. Karoli, A.P. Rebrov
Beta-blockers in patients with chronic obstructive pulmonary disease: for whom, when, how?
№5 / 2020
V.Ya. Dzerve
ENERGY METABOLISM CORRECTOR MILDRONATE®: INTERRELATION OF MECHANISMS OF ACTION AND THERAPEUTIC EFFECTS
№15 / 2017
M.A. Ayrapetyan, I.G. Gordeev, N.A. Volov
GENDER FEATURES OF ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION
№9 / 2017
V.N. Shishkova
PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY
№9 / 2017
N.A. Petunina, A.L. Terekhova
ELDERLY PATIENT WITH TYPE 2 DIABETES MELLITUS: FOCUS ON ALOGLIPTIN
№5 / 2017
L.A. Sharonova, A.F. Verbovoy, I.A. Tsanava
STATE OF CARDIOVASCULAR SYSTEM IN METABOLIC SYNDROME
№5 / 2017
E.N. Shirokova
NONALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK (LITERATURE REVIEW)
№2 / 2017
N.A. Shostak, A.A. Klimenko, D.A. Anichkov, A.A. Kondrashov
NEW MECHANISMS OF ACTION OF NSAIDS: FOCUS ON CARDIOVASCULAR SAFETY
№19 / 2016
A.F. Verbovoy, L.A. Sharonova
DIABETES MELLITUS AND CORONARY ARTERY DISEASE: FEATURES OF CLINICAL MANIFESTATION AND TREATMENT.
№16 / 2016
M.B. Antsiferov (1), G. Schernthaner (2)
CURRENT APPROACHES TO THERAPY OF TYPE 2 DIABETES MELLITUS IN THE ERA OF NEW DATA ON CARDIOVASCULAR SAFETY
№16 / 2016
E.V. Mitroshina, A.F. Verbovoy
OSTEOPOROSIS AND ATHEROSCLEROSIS: WHAT IS THE GENERAL?
№19 / 2015
A.F. Verbovoy, L.A. Sharonova, O. V. Kosareva, Yu.A. Dolgikh, N. I. Verbovaya
HYPOTHYROIDISM AND CARDIOVASCULAR DISEASES
№17 / 2015


Бионика Медиа